Condition: Testicular Germ Cell Cancer · Seminoma · Non-Seminoma Testicular Cancer · Sponsor: Haukeland University Hospital
The main objective of this study is establish the performance of miR371 in management of testicular cancer
This description comes directly from the study's public registry record.
Mette Pernille Myklebust, PhD · +47 41684492 · mette.pernille.myklebust@helse-bergen.no
Olav Dahl, PhD · +47 55972081 · olav.dahl@helse-bergen.no
Always discuss trial participation with your own doctor first.
| Haukeland University Hospital | Bergen, Norway | Recruiting |
| Haugesund Hospital | Haugesund, Norway | Recruiting |
| Oslo University Hospital | Oslo, Norway | Not Yet Recruiting |
| University Hospital of North Norway | Tromsø, Norway | Recruiting |
| Sahlgrenska University Hospital | Gothenburg, Sweden | Not Yet Recruiting |
| Karolinska University Hospital | Stockholm, Sweden | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT04914026